title: Fetal and maternal considerations in the management of stage I-B cervical cancer during pregnancy.
abstract: The timing of treatment for stage I-B cervical carcinoma diagnosed during pregnancy is complicated by conflicting concerns for fetal survival and control of malignancy. There were 11 pregnant women with stage I-B cervical carcinoma diagnosed prior to fetal viability since 1969. Six patients were managed with termination of pregnancy and radical hysterectomy with pelvic lymphadenectomy. In 5 patients, treatment was delayed for 6 to 17 weeks and then delivery was accomplished by cesarean section followed directly by radical hysterectomy and pelvic lymphadenectomy. Two of the infants experienced complicated neonatal courses and would have benefited from additional delay. Benefits that could be achieved by delaying delivery for the fetus were calculated from a review of 600 inborn infants without congenital anomalies admitted to the neonatal intensive care (NICU) during 1984 and 1985. Neonatal mortality decreased from 32.8% at 26-27 weeks to 2.7% at 34-35 weeks gestation. Similar improvements in neonatal morbidity were demonstrated. Although adverse maternal outcomes were not associated with delay, an evaluation of risk cannot be derived from this series. Significant fetal benefit can accrue from relatively short delays in planned delivery dates. When stage I-B cervical carcinoma is diagnosed during pregnancy and when fetal survival is desired, delivery should be delayed to achieve fetal maturity, rather than only potential viability.
authors.affiliation: University of Washington, Department of Obstetrics and Gynecology, Seattle 98195.
authors.forename: B E
authors.initials: BE
authors.lastname: Greer
authors.forename: T R
authors.initials: TR
authors.lastname: Easterling
authors.forename: D A
authors.initials: DA
authors.lastname: McLennan
authors.forename: T J
authors.initials: TJ
authors.lastname: Benedetti
authors.forename: J M
authors.initials: JM
authors.lastname: Cain
authors.forename: D C
authors.initials: DC
authors.lastname: Figge
authors.forename: H K
authors.initials: HK
authors.lastname: Tamimi
authors.forename: J C
authors.initials: JC
authors.lastname: Jackson
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D008297:Male; D009367:Neoplasm Staging; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000628:therapy*; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000628:therapy*